The female athlete: Some gynecologic considerations

Sports Medicine and Arthroscopy Review

Volumn 10, Issue 1, 2002, Pages 2-9

  Pfeifer, Samantha ^a   Patrizio, Pasquale ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Amenorrhea; Contraception; Menstrual cycle

Indexed keywords

CLOMIFENE CITRATE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; LIPID; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

AMENORRHEA; ARTICLE; ATHLETE; BODY FAT; BREAST DISEASE; BREAST INJURY; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; DIETARY INTAKE; EXERCISE; FEMALE; FEMALE INFERTILITY; FRACTURE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LIPID ANALYSIS; MEDICAL LITERATURE; MENSTRUAL CYCLE; MENSTRUATION DISORDER; MULTICENTER STUDY; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; RISK ASSESSMENT; SPORTS MEDICINE; STRESS;

EID: 0036051614     PISSN: 10628592     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132585-200210010-00002     Document Type: Article

References (36)

1. Modern history of women in sports
2. Delayed menarche and amenorrhea in ballet dancers
3. The effects of exercise on pubertal progression and reproductive function in girls
4. Decreased spinal mineral content in amenorrheic women
5. Scoliosis and fractures in young ballet dancers
6. Alterations in the hypothalamic-pituitary-ovarian and hypothalamic-pituitary-adrenal axes in athletic women
7. Dietary restriction reduces luteinizing hormone (LH) pulse frequency during waking hours and increases LH pulse amplitude during sleep in young menstruating women
8. Menstrual dysfunction in swimmers: A distinct entity
9. Spinal bone loss and ovulatory disturbances
10. Menstrual dysfunction in distance runners
11. Age at menarche in athletes and nonathletes
12. Menstrual history as a determinant of current bone density in young athletes
13. Pharmacologic management of athletic amenorrhea
14. The female athlete: The triad of disordered eating, amenorrhea and osteoporosis
15. Is athletic amenorrhea specific to runners?
16. Bone mineral content of amenorrheic and eumenorrheic athletes
17. Nutritional intakes and status of highly trained amenorrheic and eumenorrheic women runners
18. Attitudes toward eating and body weight in different groups of female adolescent athletes
19. The female athlete, the triad of disordered eating, amenorrhea and osteoporosis
20. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen
21. Magnetic Resonance Imaging of body fat of athletes compared with controls, and the oxidative metabolism of estradiol
22. Exercise-induced changes in enzymatic O-methylation of catecholestrogens by erythrocytes of eumenorrheic women
23. 4-hydroxycatecholestrogen metabolism responses to exercise and training: Possible implications for menstrual cycle irregularities and breast cancer
24. Inhibition of the preovulatory LH surge after a catecholestrogen (2-hydroxyestrone) antiserum injection in the third ventricle in cycling female rats
25. The role of beta-endorphins and catechol estrogens on the hypothalamic-pituitary axis in female athletes
26. Plasma concentrations of beta-endorphin in trained eumenorrheic and amenorrheic women
27. Appetite and body weight regulation: Is it all in the brain?
28. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women
29. Clinical consequences of athletic amenorrhea
30. Lack of bone accretion and amenorrhea: Evidence for relative osteopenia in weight-bearing bones
31. Bone density at weight bearing and nonweight bearing sites in ballet dancers: The effect of exercise, hypogonadism, and body weight
32. Bone mineral density after resumption of menses in amenorrheic athletes
33. Exercise-induced increase in lipid peroxidation parameters in amenorrheic female athletes
34. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy
35. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months
36. Estrogen deficiency in adolescents and young adults: Impact on bone mineral content and effects of estrogen replacement therapy